Nyxoah SA PE Ratio 2021-2024 | NYXH
Current and historical p/e ratio for Nyxoah SA (NYXH) from 2021 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Nyxoah SA PE ratio as of February 21, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Nyxoah SA PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-02-21 | 10.35 | 0.00 | |
| 2024-09-30 | 9.55 | $-1.87 | 0.00 |
| 2024-06-30 | 6.97 | $-1.61 | 0.00 |
| 2024-03-31 | 13.49 | $-1.64 | 0.00 |
| 2023-12-31 | 4.64 | $-1.68 | 0.00 |
| 2023-09-30 | 7.05 | $-1.79 | 0.00 |
| 2023-06-30 | 8.01 | $-1.74 | 0.00 |
| 2023-03-31 | 7.47 | $-1.46 | 0.00 |
| 2022-12-31 | 4.99 | $-1.26 | 0.00 |
| 2022-09-30 | 6.30 | $-0.74 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.352B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||